SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 234 filers reported holding SAGE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $6,502 | +5.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $6,174 | -81.2% | 300 | -57.1% | 0.00% | -77.8% |
| Q2 2023 | $32,914 | +12.1% | 700 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $29,372 | +112869.2% | 700 | 0.0% | 0.01% | – |
| Q4 2022 | $26 | -99.9% | 700 | 0.0% | 0.00% | – |
| Q3 2022 | $27,000 | +22.7% | 700 | 0.0% | 0.00% | – |
| Q2 2022 | $22,000 | -4.3% | 700 | 0.0% | 0.00% | – |
| Q1 2022 | $23,000 | -79.5% | 700 | -73.6% | 0.00% | – |
| Q4 2021 | $112,000 | -4.3% | 2,650 | 0.0% | 0.00% | – |
| Q3 2021 | $117,000 | -22.0% | 2,650 | 0.0% | 0.00% | – |
| Q2 2021 | $150,000 | -24.2% | 2,650 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $198,000 | -15.7% | 2,650 | -2.8% | 0.00% | 0.0% |
| Q4 2020 | $235,000 | +2.2% | 2,725 | -27.8% | 0.00% | – |
| Q3 2020 | $230,000 | +29.9% | 3,775 | -11.7% | 0.00% | – |
| Q2 2020 | $177,000 | +55.3% | 4,275 | +7.5% | 0.00% | – |
| Q1 2020 | $114,000 | – | 3,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Rock Ventures, LLC | 9,773,073 | $490,901,000 | 52.36% |
| Ghost Tree Capital, LLC | 240,000 | $12,056,000 | 2.17% |
| EcoR1 Capital, LLC | 112,455 | $5,649,000 | 1.88% |
| New Leaf Venture Partners, L.L.C. | 43,770 | $2,199,000 | 1.49% |
| AlpInvest Partners B.V. | 12,195 | $613,000 | 1.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 595,443 | $29,909,000 | 0.97% |
| APEX CAPITAL, LLC | 190,000 | $9,544,000 | 0.69% |
| OAK RIDGE INVESTMENTS LLC | 385,770 | $19,377,000 | 0.43% |
| Lombard Odier Asset Management (USA) Corp | 92,089 | $4,626,000 | 0.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 65,724 | $3,301,000 | 0.34% |